Novo Nordisk And Amazon Web Services Partner On AI Drug Discovery Hub
Novo Nordisk and Amazon Web Services will partner to use AI to accelerate drug discovery. AWS will become Novo’s preferred cloud provider and AI partner, and a collaboration hub will be created at Novo’s London facility. The agreement combines Novo’s chronic-disease knowledge with AWS cloud and AI tools, and Novo reports faster clinical documentation and improved employee productivity.
Coverage (5)
- Novo Nordisk and AWS Form Strategic Partnership to Accelerate AI-Driven Drug Discovery (biopharminternational.com)
- Novo Nordisk, AWS launch AI drug discovery hub (mobihealthnews.com)
- M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo (pharmexec.com)
- Novo Nordisk selects AWS as strategic partner to accelerate drug discovery with AI (aws.amazon.com)
- Novo Nordisk and Amazon sign AI drug discovery pact, launch London innovation hub (fiercebiotech.com)